Cargando…

Boosting of Cross-Reactive and Protection-Associated T Cells in Children After Live Attenuated Influenza Vaccination

BACKGROUND. Live attenuated influenza vaccines (LAIVs) stimulate a multifaceted immune response including cellular immunity, which may provide protection against newly emerging strains. This study shows proof of concept that LAIVs boost preexisting, cross-reactive T cells in children to genetically...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohn, Kristin G. I., Zhou, Fan, Brokstad, Karl A., Sridhar, Saranya, Cox, Rebecca J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461427/ https://www.ncbi.nlm.nih.gov/pubmed/28368530 http://dx.doi.org/10.1093/infdis/jix165

Ejemplares similares

Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines
por: Sridhar, Saranya, et al.
Publicado: (2015)

Live-Attenuated Influenza Vaccine Induces Tonsillar Follicular T Helper Cell Responses That Correlate With Antibody Induction
por: Lartey, Sarah, et al.
Publicado: (2020)

Longevity of B-Cell and T-Cell Responses After Live Attenuated Influenza Vaccination in Children
por: Mohn, Kristin G.-I., et al.
Publicado: (2015)

Early Induction of Cross-Reactive CD8(+) T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children
por: Mohn, K G-I, et al.
Publicado: (2020)

Live Attenuated Influenza Vaccine in Children Induces B-Cell Responses in Tonsils
por: Mohn, Kristin Greve-Isdahl, et al.
Publicado: (2016)

The expression of B & T cell activation markers in children's tonsils following live attenuated influenza vaccine
por: Panapasa, Jack A, et al.
Publicado: (2015)

Immune responses after live attenuated influenza vaccination
por: Mohn, Kristin G.-I., et al.
Publicado: (2018)

Correlates of Immunity to Influenza as Determined by Challenge of Children with Live, Attenuated Influenza Vaccine
por: Wright, Peter F., et al.
Publicado: (2016)

Symptom Burden and Immune Dynamics 6 to 18 Months Following Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2): A Case-control Study
por: Fjelltveit, Elisabeth B, et al.
Publicado: (2022)

Influenza Virus Detection Following Administration of Live-Attenuated Intranasal Influenza Vaccine in Children With Cystic Fibrosis and Their Healthy Siblings
por: Boikos, Constantina, et al.
Publicado: (2016)

Epidemiological Impact of the Pediatric Live Attenuated Influenza Vaccine (LAIV) Program on Group A Streptococcus (GAS) Infection in England
por: Sinnathamby, Mary A, et al.
Publicado: (2023)

Point-of-Care Influenza Testing Impacts Clinical Decision, Patient Flow, and Length of Stay in Hospitalized Adults( )
por: Fjelltveit, Elisabeth B, et al.
Publicado: (2020)

Seasonal influenza vaccination expands hemagglutinin-specific antibody breadth to older and future A/H3N2 viruses
por: Ertesvåg, Nina Urke, et al.
Publicado: (2022)

Live Attenuated Pertussis Vaccine BPZE1 Protects Baboons Against Bordetella pertussis Disease and Infection
por: Locht, Camille, et al.
Publicado: (2017)

Inflammatory Mediator Expression Associated With Antibody Response Induced by Live Attenuated vs Inactivated Influenza Virus Vaccine in Children
por: Martin, Judith M, et al.
Publicado: (2018)

Live-Attenuated Influenza Vaccine Effectiveness in Children From 2009 to 2015–2016: A Systematic Review and Meta-Analysis
por: Caspard, Herve, et al.
Publicado: (2017)

Pan-Influenza A Protection by Prime–Boost Vaccination with Cold-Adapted Live-Attenuated Influenza Vaccine in a Mouse Model
por: Jang, Yo Han, et al.
Publicado: (2018)

SARS-CoV-2–Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study
por: Trieu, Mai-Chi, et al.
Publicado: (2020)

Streptococcus pyogenes Colonization in Children Aged 24–59 Months in the Gambia: Impact of Live Attenuated Influenza Vaccine and Associated Serological Responses
por: Keeley, Alexander J, et al.
Publicado: (2023)

Safety of Recombinant Influenza Vaccine Compared to Inactivated Influenza Vaccine in Adults: An Observational Study
por: Hansen, John, et al.
Publicado: (2020)

Effects of Prior Influenza Exposure on Immunogenicity of Influenza Vaccine
por: Cao, Jia-Qian, et al.
Publicado: (2020)

Vaccination with Adjuvanted Recombinant Neuraminidase Induces Broad Heterologous, but Not Heterosubtypic, Cross-Protection against Influenza Virus Infection in Mice
por: Wohlbold, Teddy John, et al.
Publicado: (2015)

Inactivated and live-attenuated seasonal influenza vaccines boost broadly neutralizing antibodies in children
por: Yegorov, Sergey, et al.
Publicado: (2022)

Cross-Protective Immune Responses Elicited by Live Attenuated Influenza Vaccines
por: Jang, Yo Han, et al.
Publicado: (2013)

Antibodies Produced in Response to a Live-Attenuated Dengue Vaccine Are Functional in Activating the Complement System
por: Nascimento, Eduardo J M, et al.
Publicado: (2022)

Local and systemic cytokine and chemokine responses after parenteral influenza vaccination
por: Eriksson, Jens‐Christian, et al.
Publicado: (2007)

High Prevalence of Humoral and Cellular Immunity to Influenza Viruses in Preschool Children Living in Addis Ababa, Ethiopia
por: Dembinski, Jennifer L., et al.
Publicado: (2017)

An RSV Live-Attenuated Vaccine Candidate Lacking G Protein Mucin Domains Is Attenuated, Immunogenic, and Effective in Preventing RSV in BALB/c Mice
por: Roe, Molly K, et al.
Publicado: (2022)

Live Attenuated Zoster Vaccine Boosts Varicella Zoster Virus (VZV)–Specific Humoral Responses Systemically and at the Cervicovaginal Mucosa of Kenyan VZV-Seropositive Women
por: Perciani, Catia T, et al.
Publicado: (2018)

Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9)
por: Sobhanie, Mahdee, et al.
Publicado: (2016)

Safety of Live-Attenuated Measles, Mumps, and Rubella Vaccine Administered Within 2 Years of Hematopoietic Cell Transplant
por: Desjardins, Michaël, et al.
Publicado: (2021)

Clinical Safety Experience of TAK-003 for Dengue Fever: A New Tetravalent Live Attenuated Vaccine Candidate
por: Patel, Sanjay S, et al.
Publicado: (2022)

The human potential of a recombinant pandemic influenza vaccine produced in tobacco plants
por: Jul-Larsen, Åsne, et al.
Publicado: (2012)

Boosting Immunity in Recipients of Live-Attenuated Zoster Vaccine
por: Schmid, D. Scott
Publicado: (2016)

SARS-CoV-2 infection induces long-lived B and T-cell responses up to 15 months post-infection, irrespective of disease severity
por: Mohn, Kristin G-I, et al.
Publicado: (2023)

Live attenuated influenza vaccine induces broadly cross-reactive mucosal antibody responses to different influenza strains in tonsils
por: Mahallawi, Waleed H., et al.
Publicado: (2023)

Intradermal vaccination of live attenuated influenza vaccine protects mice against homologous and heterologous influenza challenges
por: Lee, Andrew Chak-Yiu, et al.
Publicado: (2021)

Boosted Influenza-Specific T Cell Responses after H5N1 Pandemic Live Attenuated Influenza Virus Vaccination
por: Peng, YanChun, et al.
Publicado: (2015)

Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza Vaccines
por: Sridhar, Saranya
Publicado: (2016)

Protective Effect of Maternal Influenza Vaccination on Influenza in Their Infants: A Prospective Cohort Study
por: Ohfuji, Satoko, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tinvlflp59ctoig3agmg0cqvi6